Drug intelligence / Profile preview

pregabalin + imipramine

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

The combination of pregabalin and imipramine is used for treating painful polyneuropathy. This combination therapy uses moderate doses of both medications to provide better pain relief than monotherapy with either drug alone. Pregabalin is an anticonvulsant that binds to the α2δ subunit of voltage-dependent calcium channels, while imipramine is a tricyclic antidepressant that inhibits serotonin and norepinephrine reuptake. Clinical trials have shown that the combination provides significantly better pain reduction compared to either medication used alone, though it may cause more side effects including dizziness, drowsiness, confusion, and difficulty concentrating.

Other names
imipramine and pregabalin combination
02

Targets

CACNA2D2 (α2δ-2)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)

Beyond the preview

Go deeper on pregabalin + imipramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pregabalin + imipramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call